Clinical Trial Update: StaphVAX Immunogenicity and Safety in Orthopaedic Joint Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating immunogenicity and safety of StaphVAX in orthopaedic joint surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcal Infections

Drugs mentioned

• StaphVAX

Snippet

Sponsor: Nabi Biopharmaceuticals | Conditions: Staphylococcal Infections | Phase 3 | Status: COMPLETED